NIBI is the New International Business Institute created by the Milan Chamber of Commerce and Promos.
The mission of NIBI is to promote the training and updating of the human resources of companies that need to compete at international level, identifying new outlet, procurement, and production markets.
NIBI is the only management school that relies on a Foreign Network of offices located on the world’s strategic markets. Its top-level Faculty and the experience developed by Promos in its co-operation with companies result into training courses where education and contents are focused on instruments, relations, and experience, as well as on basic theory.
With an educational offering exclusively focused on international business, NIBI aims to become a reference model in executive education for micro, small and medium enterprises.
Denmark Patient Monitoring Market Outlook to 2018 - Fetal Monitors, Multipara...ReportsnReports
This document provides a 173-page report on the Denmark patient monitoring market outlook from 2012 to 2018. It includes market segmentation data, revenue and volume forecasts, average pricing, and company market shares for various patient monitoring product categories including fetal monitors, multiparameter monitors, neonatal monitors, non-invasive blood pressure monitors, and others. Major companies covered in the report include Philips Healthcare, GE Healthcare, and Draegerwerk AG & Co. KGaA. The report is based on proprietary research and is intended to help readers develop business and market strategies for the Denmark patient monitoring industry.
Kidney Cancer (Renal Cell Cancer) Global Clinical Trials Review, H2, 2012ReportsnReports
This document provides a 139-page report on global clinical trials for kidney cancer (renal cell cancer) in the second half of 2012. It includes data on the number and location of clinical trials, breakdown of trials by phase, status, subject recruitment, and leading sponsors. The report aims to give an overview of the clinical trial landscape and assess trends in research and development for treating kidney cancer worldwide.
Saudi Arabia Anesthesia and Respiratory Devices Market Outlook to 2018 - Resp...ReportsnReports
This document provides a summary of a 278-page report from GlobalData analyzing the anesthesia and respiratory devices market in Saudi Arabia. The report segments the market into 8 categories and provides historical revenue and forecast data from 2004-2018 for each segment. It also provides company share and distribution data. Key players in the Saudi Arabia market that are profiled include GE Healthcare, Draegerwerk AG, Covidien, ResMed, and others. The report is intended to help companies develop business and market strategies for opportunities in the Saudi anesthesia and respiratory devices market.
The Insurance Industry in Sweden, Key Trends and Opportunities to 2016ReportsnReports
The document provides an in-depth analysis of the insurance industry in Sweden from 2007-2016. It analyzes trends in life, non-life, and health insurance segments and provides historical data and forecasts. It also examines the competitive landscape and discusses top insurance companies. The Swedish insurance industry grew at a CAGR of 4.2% during 2007-2011, led by growth in the life insurance segment. Domestic insurers dominate the market, though international companies are showing interest in the Swedish market.
el flujo de efectivo han sufrido cambios con el paso del tiempo, y las necesidades de información cada día es más demandante por los usuarios de la misma, el objeto de la información financiera es ser útil para la toma de decisiones que le permita al usuario saber y evaluar a determinada organización.y el buen funcionamiento para la empresa
NIBI is the New International Business Institute created by the Milan Chamber of Commerce and Promos.
The mission of NIBI is to promote the training and updating of the human resources of companies that need to compete at international level, identifying new outlet, procurement, and production markets.
NIBI is the only management school that relies on a Foreign Network of offices located on the world’s strategic markets. Its top-level Faculty and the experience developed by Promos in its co-operation with companies result into training courses where education and contents are focused on instruments, relations, and experience, as well as on basic theory.
With an educational offering exclusively focused on international business, NIBI aims to become a reference model in executive education for micro, small and medium enterprises.
Denmark Patient Monitoring Market Outlook to 2018 - Fetal Monitors, Multipara...ReportsnReports
This document provides a 173-page report on the Denmark patient monitoring market outlook from 2012 to 2018. It includes market segmentation data, revenue and volume forecasts, average pricing, and company market shares for various patient monitoring product categories including fetal monitors, multiparameter monitors, neonatal monitors, non-invasive blood pressure monitors, and others. Major companies covered in the report include Philips Healthcare, GE Healthcare, and Draegerwerk AG & Co. KGaA. The report is based on proprietary research and is intended to help readers develop business and market strategies for the Denmark patient monitoring industry.
Kidney Cancer (Renal Cell Cancer) Global Clinical Trials Review, H2, 2012ReportsnReports
This document provides a 139-page report on global clinical trials for kidney cancer (renal cell cancer) in the second half of 2012. It includes data on the number and location of clinical trials, breakdown of trials by phase, status, subject recruitment, and leading sponsors. The report aims to give an overview of the clinical trial landscape and assess trends in research and development for treating kidney cancer worldwide.
Saudi Arabia Anesthesia and Respiratory Devices Market Outlook to 2018 - Resp...ReportsnReports
This document provides a summary of a 278-page report from GlobalData analyzing the anesthesia and respiratory devices market in Saudi Arabia. The report segments the market into 8 categories and provides historical revenue and forecast data from 2004-2018 for each segment. It also provides company share and distribution data. Key players in the Saudi Arabia market that are profiled include GE Healthcare, Draegerwerk AG, Covidien, ResMed, and others. The report is intended to help companies develop business and market strategies for opportunities in the Saudi anesthesia and respiratory devices market.
The Insurance Industry in Sweden, Key Trends and Opportunities to 2016ReportsnReports
The document provides an in-depth analysis of the insurance industry in Sweden from 2007-2016. It analyzes trends in life, non-life, and health insurance segments and provides historical data and forecasts. It also examines the competitive landscape and discusses top insurance companies. The Swedish insurance industry grew at a CAGR of 4.2% during 2007-2011, led by growth in the life insurance segment. Domestic insurers dominate the market, though international companies are showing interest in the Swedish market.
el flujo de efectivo han sufrido cambios con el paso del tiempo, y las necesidades de información cada día es más demandante por los usuarios de la misma, el objeto de la información financiera es ser útil para la toma de decisiones que le permita al usuario saber y evaluar a determinada organización.y el buen funcionamiento para la empresa
Spain Molecular Diagnostics Market: Innovative Technologies and Emerging Busi...ReportsnReports
This 860-page report provides a comprehensive analysis of the molecular diagnostics market in Spain, including key trends, technologies, major applications and suppliers. It covers topics such as DNA sequencing, probe technologies, detection methods, instrumentation, emerging applications in oncology, infectious diseases and pharmacogenomics. The report also identifies over 60 specific business opportunities and strategies for companies to enter the Spanish molecular diagnostics market.
India continues to rank relatively low in terms of human development, placing 134th out of 187 countries according to the 2011 Human Development Report. While India has made progress increasing life expectancy and years of schooling, it still lags behind many of its neighbors. Female representation in Indian politics remains very low at just 10.7% in parliament, and India has a higher rate of multidimensional poverty than indices of income poverty alone would suggest.
An afro arab spring - socio-political trajectories in stemming the tide of th...Costy Costantinos
The financial, economic and for many, the livelihood, crisis that erupted in 2008 showed a cliffy downward freefall of economic trajectories unheard of in recent memory. The outbreak of the financial crisis provoked a broad liquidation of investments, substantial loss in wealth worldwide, a tightening of lending conditions, and a widespread increase in uncertainty. Higher borrowing costs and tighter credit conditions, coupled with the increase in uncertainty provoked a global flight to quality, caused firms to cut back on investment expenditures, and households to delay purchases of big-ticket items. Unemployment is on the rise, bringing with it a substantial deterioration in conditions for the most vulnerable. The sharp rise in commodity prices eventually resulted in The Arab Spring
Effective states & engaged societies the nature of statal policy and instit...Costy Costantinos
This document discusses the concept of the developmental state and examines whether Ethiopia can establish one. It begins by defining the developmental state and exploring the ideological forces behind developmental dirigism. It then examines the rise and fall of developmental states in Japan and East Asia. It analyzes challenges facing African developmental states, including analytical disconnects, issues of good practices and wrong lessons, government and market failures, and neo-patrimonialism. The document considers Ethiopia's massive resources and argues it can finance infrastructure if leadership commits to industrialization and high-income opportunities. It concludes by recommending Ethiopia avoid pitfalls, enhance the state's role in transformation, de-link the state from rent-seekers, and nurt
2012 China Elevator Development Forecast ReportReportsnReports
This document is a 338-page research report on China's elevator industry published in November 2012. It provides an in-depth overview of the industry, including definitions, classifications, manufacturing processes, production and sales data from 2009-2016 for 49 Chinese elevator manufacturers, analysis of supply, demand and the competitive landscape, and profiles of individual manufacturers. The report aims to help understand the current state and future trends of China's elevator industry.
Spain Molecular Diagnostics Market: Innovative Technologies and Emerging Busi...ReportsnReports
This 860-page report provides a comprehensive analysis of the molecular diagnostics market in Spain, including key trends, technologies, major applications and suppliers. It covers topics such as DNA sequencing, probe technologies, detection methods, instrumentation, emerging applications in oncology, infectious diseases and pharmacogenomics. The report also identifies over 60 specific business opportunities and strategies for companies to enter the Spanish molecular diagnostics market.
India continues to rank relatively low in terms of human development, placing 134th out of 187 countries according to the 2011 Human Development Report. While India has made progress increasing life expectancy and years of schooling, it still lags behind many of its neighbors. Female representation in Indian politics remains very low at just 10.7% in parliament, and India has a higher rate of multidimensional poverty than indices of income poverty alone would suggest.
An afro arab spring - socio-political trajectories in stemming the tide of th...Costy Costantinos
The financial, economic and for many, the livelihood, crisis that erupted in 2008 showed a cliffy downward freefall of economic trajectories unheard of in recent memory. The outbreak of the financial crisis provoked a broad liquidation of investments, substantial loss in wealth worldwide, a tightening of lending conditions, and a widespread increase in uncertainty. Higher borrowing costs and tighter credit conditions, coupled with the increase in uncertainty provoked a global flight to quality, caused firms to cut back on investment expenditures, and households to delay purchases of big-ticket items. Unemployment is on the rise, bringing with it a substantial deterioration in conditions for the most vulnerable. The sharp rise in commodity prices eventually resulted in The Arab Spring
Effective states & engaged societies the nature of statal policy and instit...Costy Costantinos
This document discusses the concept of the developmental state and examines whether Ethiopia can establish one. It begins by defining the developmental state and exploring the ideological forces behind developmental dirigism. It then examines the rise and fall of developmental states in Japan and East Asia. It analyzes challenges facing African developmental states, including analytical disconnects, issues of good practices and wrong lessons, government and market failures, and neo-patrimonialism. The document considers Ethiopia's massive resources and argues it can finance infrastructure if leadership commits to industrialization and high-income opportunities. It concludes by recommending Ethiopia avoid pitfalls, enhance the state's role in transformation, de-link the state from rent-seekers, and nurt
2012 China Elevator Development Forecast ReportReportsnReports
This document is a 338-page research report on China's elevator industry published in November 2012. It provides an in-depth overview of the industry, including definitions, classifications, manufacturing processes, production and sales data from 2009-2016 for 49 Chinese elevator manufacturers, analysis of supply, demand and the competitive landscape, and profiles of individual manufacturers. The report aims to help understand the current state and future trends of China's elevator industry.
Thymus Cancer Global Clinical Trials Review, H2, 2012
1. Thymus Cancer Global Clinical Trials Review, H2, 2012
Report Details:
Published:November 2012
No. of Pages: 99
Price: Single User License – US$2500
Thymus Cancer Global Clinical Trials Review, H2, 2012
Summary
GlobalData''s clinical trial report, “Thymus Cancer Global Clinical Trials Review, H2, 2012"
provides data on the Thymus Cancer clinical trial scenario. This report provides elemental
information and data relating to the clinical trials on Thymus Cancer. It includes an overview of the
trial numbers and their recruitment status as per the site of trial conduction across the globe. The
databook offers a preliminary coverage of disease clinical trials by their phase, trial status,
prominence of the sponsors and also provides briefing pertaining to the number of trials for the key
drugs for treating Thymus Cancer. This report is built using data and information sourced from
proprietary databases, primary and secondary research and in-house analysis by GlobalData''s
team of industry experts.
Note: Certain sections in the report may be removed or altered based on the availability and
relevance of data for the indicated disease.
Scope
- Data on the number of clinical trials conducted in North America, South and Central America,
Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along
with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and
sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy
- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location,
sponsor type and many more
2. - Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Get your copy of this report @
http://www.reportsnreports.com/reports/210596-thymus-cancer-global-clinical-trials-review-h2-2012.html
Major points covered in Table of Contents of this report include
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Thymus Cancer 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Clinical Trials by BRIC Nations 14
Clinical Trials by G7 Nations 15
Clinical Trials in G7 Nations by Trial Status 16
Clinical Trials by E7 Nations 17
Clinical Trials in E7 Nations by Trial Status 18
Clinical Trials by Phase 19
In Progress Trials by Phase 20
Clinical Trials by Trial Status 21
Unaccomplished Trials of Thymus Cancer 22
Subjects Recruited Over a Period of Time 23
Prominent Sponsors 24
Top Companies Participating in Thymus Cancer Therapeutics Clinical Trials 26
Prominent Drug Comparison 27
Clinical Trial Profiles 28
Clinical Trial Overview of Top Companies 28
Nerviano Medical Sciences S.r.l. 28
Clinical Trial Overview of Nerviano Medical Sciences S.r.l. 28
Novartis AG 29
Clinical Trial Overview of Novartis AG 29
ZIOPHARM Oncology, Inc. 30
Clinical Trial Overview of ZIOPHARM Oncology, Inc. 30
Clinical Trial Overview of Top Universities / Institutes / Hospitals 31
Stanford University 31
3. Clinical Trial Overview of Stanford University 31
Indiana University 32
Clinical Trial Overview of Indiana University 32
Memorial Sloan Kettering Cancer Center 33
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center 33
Istituto Clinico Humanitas 34
Clinical Trial Overview of Istituto Clinico Humanitas 34
Indiana University School of Medicine 35
Clinical Trial Overview of Indiana University School of Medicine 35
Shanghai Chest Hospital 36
Clinical Trial Overview of Shanghai Chest Hospital 36
Shinshu University 37
Clinical Trial Overview of Shinshu University 37
Kumamoto University 38
Clinical Trial Overview of Kumamoto University 38
Valley Health System 39
Clinical Trial Overview of Valley Health System 39
Tohoku University 40
Clinical Trial Overview of Tohoku University 40
St. Luke''s-Roosevelt Hospital Center 41
Clinical Trial Overview of St. Luke''s-Roosevelt Hospital Center 41
Charite- Universitatsmedizin Berlin 42
Clinical Trial Overview of Charite- Universitatsmedizin Berlin 42
UCLA''s Jonsson Comprehensive Cancer Center 43
Clinical Trial Overview of UCLA''s Jonsson Comprehensive Cancer Center 43
Samsung Medical Center 44
Clinical Trial Overview of Samsung Medical Center 44
Faculty of Pharmaceutical Sciences, Chulalongkorn University 45
Clinical Trial Overview of Faculty of Pharmaceutical Sciences, Chulalongkorn University 45
Duke University 46
Clinical Trial Overview of Duke University 46
University of Wisconsin Madison 47
Clinical Trial Overview of University of Wisconsin Madison 47
Fox Chase Cancer Center 48
Clinical Trial Overview of Fox Chase Cancer Center 48
The University of Texas M. D. Anderson Cancer Center 49
Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center 49
Five Key Clinical Profiles 50
Appendix 96
Abbreviations 96
Definitions 96
Research Methodology 97
4. Secondary Research 98
About GlobalData 98
Contact Us 98
Disclaimer 98
Source 99
List of Tables
Thymus Cancer Therapeutics Market, Global, Clinical Trials by Zone, 2012* 7
Thymus Cancer Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 8
Thymus Cancer Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012*
9
Thymus Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2012* 10
Thymus Cancer Therapeutics Clinical Trials, Europe, Top Countries, 2012* 11
Thymus Cancer Therapeutics Clinical Trials, North America, Top Countries, 2012* 12
Thymus Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2012* 13
Thymus Cancer Therapeutics Clinical Trials, BRIC Countries, 2012* 14
Thymus Cancer Therapeutics Clinical Trials, G7 Countries, 2012* 15
Thymus Cancer Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 16
Thymus Cancer Therapeutics Clinical Trials, E7 Countries, 2012* 17
Thymus Cancer Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012* 18
Thymus Cancer Therapeutics Market, Global, Clinical Trials by Phase, 2012* 19
Thymus Cancer Therapeutics Market, Global, Clinical Trials In Progress by Phase 2012* 20
Thymus Cancer Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 21
Thymus Cancer Therapeutics Market, Global, Terminated Clinical Trials, 2012* 22
Thymus Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2006-
2011 23
Thymus Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 25
Thymus Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 26
Thymus Cancer Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 27
Thymus Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Nerviano Medical
Sciences S.r.l., 2012* 28
Thymus Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2012*
29
Thymus Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by ZIOPHARM
Oncology, Inc., 2012* 30
Thymus Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Stanford University,
2012* 31
Thymus Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Indiana University,
2012* 32
Thymus Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan
Kettering Cancer Center, 2012* 33
Thymus Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Istituto Clinico
5. Humanitas, 2012* 34
Thymus Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Indiana University
School of Medicine, 2012* 35
Thymus Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Shanghai Chest
Hospital, 2012* 36
Thymus Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Shinshu University,
2012* 37
Thymus Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Kumamoto
University, 2012* 38
Thymus Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Valley Health
System, 2012* 39
Thymus Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Tohoku University,
2012* 40
Thymus Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by St. Luke''s-Roosevelt
Hospital Center, 2012* 41
Thymus Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Charite-
Universitatsmedizin Berlin, 2012* 42
Thymus Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by UCLA''s Jonsson
Comprehensive Cancer Center, 2012* 43
Thymus Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Samsung Medical
Center, 2012* 44
Thymus Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Faculty of
Pharmaceutical Sciences, Chulalongkorn University, 2012* 45
Thymus Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Duke University,
2012* 46
Thymus Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of
Wisconsin Madison, 2012* 47
Thymus Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Fox Chase Cancer
Center, 2012* 48
Thymus Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of
Texas M. D. Anderson Cancer Center, 2012* 49
List of Figures
Thymus Cancer Therapeutics Market, Global, Clinical Trials by Zone (%), 2012* 7
Thymus Cancer Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 8
Thymus Cancer Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012*
9
Thymus Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2012* 10
Thymus Cancer Therapeutics Clinical Trials, Europe, Top Countries (%), 2012* 11
Thymus Cancer Therapeutics Clinical Trials, North America, Top Countries (%), 2012* 12
Thymus Cancer Therapeutics Clinical Trials, G7 Countries (%), 2012* 15
Thymus Cancer Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 16
6. Thymus Cancer Therapeutics Market, Global, Clinical Trials by Phase (%), 2012* 19
Thymus Cancer Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2012* 20
Thymus Cancer Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 21
Thymus Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2006-
2011 23
Thymus Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 24
Thymus Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 26
Thymus Cancer Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 27
GlobalData Methodology 97
Contact: sales@reportsandreports.com for more information.